These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 35502084)

  • 21. Unusual association of orbital tumour and rhino-orbital-cerebral mucormycosis.
    Verma R; Chakraborty R
    BMJ Case Rep; 2022 Aug; 15(8):. PubMed ID: 35999020
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rhino-orbital mucormycosis following COVID-19 in previously non-diabetic, immunocompetent patients.
    Nair AG; Adulkar NG; D'Cunha L; Rao PR; Bradoo RA; Bapaye MM; Kothari A; Dave TV; Shinde CA
    Orbit; 2021 Dec; 40(6):499-504. PubMed ID: 34338124
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Orbital infarction syndrome secondary to rhino-orbital mucormycosis in a case of COVID-19: Clinico-radiological features.
    Rao R; Shetty AP; Nagesh CP
    Indian J Ophthalmol; 2021 Jun; 69(6):1627-1630. PubMed ID: 34011758
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spectrum of orbital fat necrosis in rhino-orbital-cerebral mucormycosis in post-COVID-19 patients.
    Agrawal A; Diwaker P; Dixit S; Rohatgi J; Arora VK
    Indian J Ophthalmol; 2024 Oct; 72(10):1478-1482. PubMed ID: 39331438
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rhino-Orbital Cerebral Mucormycosis in a Diabetic Patient: An Emergency Medicine Case Report.
    Sweet R; Hovenden M; Harvey CE; Peterson W; Lott I
    J Emerg Med; 2023 Mar; 64(3):385-387. PubMed ID: 36932004
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Managing mucormycosis in diabetic patients: A case report with critical review of the literature.
    Beiglboeck FM; Theofilou NE; Fuchs MD; Wiesli MG; Leiggener C; Igelbrink S; Augello M
    Oral Dis; 2022 Apr; 28(3):568-576. PubMed ID: 33583133
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bilateral ophthalmic artery occlusion in rhino-orbito-cerebral mucormycosis.
    Song YM; Shin SY
    Korean J Ophthalmol; 2008 Mar; 22(1):66-9. PubMed ID: 18323710
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rhino-orbital mucormycosis during steroid therapy in COVID-19 patients: A case report.
    Veisi A; Bagheri A; Eshaghi M; Rikhtehgar MH; Rezaei Kanavi M; Farjad R
    Eur J Ophthalmol; 2022 Jul; 32(4):NP11-NP16. PubMed ID: 33843287
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Secondary central retinal artery occlusion due to rhino-orbital-cerebral mucormycosis in a diabetic patient: a case report.
    Sumual V; Lukandy A; Sutanto RL
    Ann Med Surg (Lond); 2024 Jan; 86(1):507-511. PubMed ID: 38222772
    [TBL] [Abstract][Full Text] [Related]  

  • 30. First report of rhino-orbital-cerebral mucormycosis after COVID-19 infection in Bulgaria.
    Niyazi D; Toncheva B; Tonchev T; Dzhenkov D; Kalchev K; Stoeva T
    Future Microbiol; 2022 Sep; 17():1107-1113. PubMed ID: 35899489
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rhino-Orbital Cerebral Mucormycosis in Non-Diabetic Patients with COVID-19.
    Elhamamsy S; Bayer T; Al-Kaffas M; Hatahet S; Grover M; Samdhani S; Nanda A; Gravenstein S
    R I Med J (2013); 2021 Oct; 104(8):19-21. PubMed ID: 34582509
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinico-Radiological-Pathological Correlation of Visual Loss in COVID-Associated Rhino-Orbito-Cerebral Mucormycosis.
    Goel R; Arora R; Shah S; Chhabra M; Kumar J; Khurana N; Gupta S; Khanam S; Kumar S; Singh S; Meher R; Thakar M; Garg A
    Ophthalmic Plast Reconstr Surg; 2022 May-Jun 01; 38(3):242-249. PubMed ID: 34919070
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The ROC Staging System for COVID-related Rhino-Orbital-Cerebral Mucormycosis.
    Naik MN; Rath S
    Semin Ophthalmol; 2022 Apr; 37(3):279-283. PubMed ID: 34260342
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Frontal osteomyelitis post-COVID-19 associated mucormycosis.
    Kulkarni P; Beeraka D; Tanwar M; Kim U; Ganesan RM; Saini P
    Indian J Ophthalmol; 2023 Jul; 71(7):2906-2910. PubMed ID: 37417145
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of Serum Iron Studies in COVID Associated Mucormycosis with Stage of the Disease.
    Rao C; R M
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443509
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Corneal manifestations and treatment among patients with COVID-19-associated rhino-orbito-cerebral mucormycosis.
    Yadav R; Madan S; Rohatgi J; Sahu PK; Das S; Tandon A; Rai P; Verma P; Singh J; Bajaj I
    Indian J Ophthalmol; 2023 Jan; 71(1):101-108. PubMed ID: 36588217
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A clinico-pathological study of COVID-19 associated rhino-orbital-cerebral mucormycosis.
    Mani S; Thirunavukkarasu A
    Indian J Ophthalmol; 2022 Mar; 70(3):1013-1018. PubMed ID: 35225563
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Secondary infection with rhino-orbital cerebral mucormycosis associated with COVID-19.
    Dallalzadeh LO; Ozzello DJ; Liu CY; Kikkawa DO; Korn BS
    Orbit; 2022 Oct; 41(5):616-619. PubMed ID: 33752571
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcomes of transcutaneous retrobulbar Amphotericin B (TRAMB) as an adjuvant therapy for rhino-orbital-cerebral mucormycosis (ROCM) following COVID-19.
    Shakrawal J; Sharma V; Goyal A; Kumar D; Meena S; Tiwari S; Jain V; Elhence P; Soni K; Choudhury B; Bhatnagar K; Garg MK; Misra S
    Int Ophthalmol; 2023 Jun; 43(6):1919-1926. PubMed ID: 36427099
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Presentation and outcome of rhino-orbital-cerebral mucormycosis in patients with diabetes.
    Bhansali A; Bhadada S; Sharma A; Suresh V; Gupta A; Singh P; Chakarbarti A; Dash RJ
    Postgrad Med J; 2004 Nov; 80(949):670-4. PubMed ID: 15537854
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.